Kevin Roe

659 total citations
37 papers, 406 citations indexed

About

Kevin Roe is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kevin Roe has authored 37 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Kevin Roe's work include Respiratory viral infections research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Kevin Roe is often cited by papers focused on Respiratory viral infections research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Kevin Roe collaborates with scholars based in United States, Netherlands and Belarus. Kevin Roe's co-authors include Erik Lehman, Nasrollah Ghahramani, Ming Wang, Ankita Tandon, Kathleen M. Roe and John K. Harcourt and has published in prestigious journals such as Journal of the American Society of Nephrology, Pharmaceutical Research and Drug Discovery Today.

In The Last Decade

Kevin Roe

29 papers receiving 374 citations

Peers

Kevin Roe

IMMUN

MB

ID

EPIDE

ONCOL

Lucas S. Ribeiro Brazil

Tuan Thanh Chau Vietnam

Jing Ding China

John Quiroga Chile

Xiaohua Yang China

Yang Fu China

Waliza Ansar India

Marta Popiel Poland

Siyi He China

Anthony A. Azenabor United States

Lucas S. Ribeiro Brazil

Kevin Roe

95 ×0.9

IMMUN

127 ×1.5

MB

76 ×1.3

ID

92 ×1.8

EPIDE

25 ×0.6

ONCOL

Citations per year, relative to Kevin Roe Kevin Roe (= 1×) peers Lucas S. Ribeiro

Countries citing papers authored by Kevin Roe

Since Specialization

Citations

This map shows the geographic impact of Kevin Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Roe more than expected).

Fields of papers citing papers by Kevin Roe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Roe. The network helps show where Kevin Roe may publish in the future.

Co-authorship network of co-authors of Kevin Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Roe. A scholar is included among the top collaborators of Kevin Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Roe. Kevin Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Roe, Kevin. (2025). Herpesvirus initiation of dementias and autoimmune diseases. Journal of NeuroVirology. 31(4). 305–332.

2.

Roe, Kevin. (2025). Preeclampsia and eclampsia: the role of hemolytic protozoan iron. Advances in clinical chemistry. 125. 169–194. 1 indexed citations

3.

Roe, Kevin. (2025). Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites. Vascular Pharmacology. 161. 107552–107552.

4.

Roe, Kevin. (2024). Lethal Synergistic Infections by Two Concurrent Respiratory Pathogens. Archives of Medical Research. 56(1). 103101–103101. 1 indexed citations

5.

Roe, Kevin. (2024). Immunoregulatory natural killer cells. Clinica Chimica Acta. 558. 117896–117896. 5 indexed citations

6.

Roe, Kevin. (2024). Are secondary bacterial pneumonia mortalities increased because of insufficient pro-resolving mediators?. Journal of Infection and Chemotherapy. 30(10). 959–970. 5 indexed citations

7.

Roe, Kevin. (2023). A latent pathogen infection classification system that would significantly increase healthcare safety. Immunologic Research. 71(5). 673–677. 4 indexed citations

8.

Roe, Kevin. (2023). A mammalian lung's immune system minimizes tissue damage by initiating five major sequential phases of defense. Clinical and Experimental Medicine. 23(7). 2967–2977. 2 indexed citations

9.

Roe, Kevin. (2023). Treatment alternatives for multidrug-resistant fungal pathogens. Drug Discovery Today. 28(6). 103596–103596. 5 indexed citations

10.

Roe, Kevin. (2023). Eight influenza virus cellular manipulations which can boost concurrent SARS-CoV-2 infections to severe outcomes. Human Cell. 36(5). 1581–1592. 5 indexed citations

11.

Roe, Kevin. (2023). Deadly interactions: Synergistic manipulations of concurrent pathogen infections potentially enabling future pandemics. Drug Discovery Today. 28(11). 103762–103762.

12.

Roe, Kevin. (2022). Autism Spectrum Disorder Initiation by Inflammation-Facilitated Neurotoxin Transport. Neurochemical Research. 47(5). 1150–1165. 12 indexed citations

13.

Roe, Kevin. (2021). An Alternative Explanation for Alzheimer’s Disease and Parkinson’s Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins. Neurochemical Research. 47(3). 517–530. 34 indexed citations

14.

Roe, Kevin. (2021). How major fungal infections can initiate severe autoimmune diseases. Microbial Pathogenesis. 161(Pt A). 105200–105200. 8 indexed citations

15.

Roe, Kevin. (2021). The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 272(1). 167–168. 13 indexed citations

16.

Roe, Kevin. (2021). The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasma gondii. Microbial Pathogenesis. 161(Pt B). 105299–105299. 4 indexed citations

17.

Roe, Kevin. (2021). The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections. Journal of Neuroimmune Pharmacology. 16(3). 513–516. 15 indexed citations

18.

Roe, Kevin. (2020). A Proposed Treatment Approach to Treat Lethal Mutating Cancers. Pharmaceutical Research. 37(3). 54–54. 1 indexed citations

19.

Tandon, Ankita, et al.. (2016). Nephrologists' likelihood of referring patients for kidney transplant based on hypothetical patient scenarios. Clinical Kidney Journal. 9(4). 611–615. 17 indexed citations

20.

Roe, Kevin, et al.. (2013). Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease. Nephron Clinical Practice. 123(1-2). 61–66. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact